Rtw Investments, LP Akero Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 7,419,340 shares of AKRO stock, worth $382 Million. This represents 4.92% of its overall portfolio holdings.
Number of Shares
7,419,340
Previous 6,859,823
8.16%
Holding current value
$382 Million
Previous $191 Million
57.37%
% of portfolio
4.92%
Previous 3.11%
Shares
5 transactions
Others Institutions Holding AKRO
# of Institutions
268Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Janus Henderson Group PLC London, X07.07MShares$364 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$306 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$288 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$270 Million7.15% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.82MShares$248 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.39B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...